Skip to content

PHARM-AD

Active Private limited companyfounded 2009active for 17 yearsRue Sainte-Gertrude (Piét.) 5, 1370 JodoigneKBO/BCE: BE 0819.236.165 #10 company by equity in Jodoigne, Administrative and support services sector

Lifetime

16 annual accounts with figures on one time axis
peak of €262,607 in 2024
€222,322▼ 15.3%
peak of €179,337 in 2024
€150,580▼ 16.0%
peak of €476,654 in 2025
€476,654▲ 0.7%
€182,653▼ 29.7%
Board2 names since 2009
2 directors and 1 other
Documentsfilings and deeds
30-01-20261 day before the deadline
2025micro format
Gross margin from €262,607 to €222,322Dividend €147,110Debts from €259,755 to €182,653Investments €8,567

Key points

from the 2025 annual accounts

Equity

€476,654 ▲ 0.7%
473,1842024+150,580Profit-147,110Dividend476,6542025

PHARM-AD paid out €147,110 in dividends. That is 98% of the 2025 profit.

Investments

€12,517 43.5 times depreciation
20242025

Green is investment, beige is depreciation.

Filings

16 annual accounts since 2010
deadline2010201520202025

The last five annual accounts were filed 1 to 32 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as PHARM-AD has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for PHARM-AD. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

Assemblee Generale - Annee Comptable General meeting of 04-05-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0819236165
changes role from manager to director appointed as director · General meeting of 27-12-2023 · Gazette deed
Incorporation published on 07-10-2009 · Gazette deed
All 28 events

Comparable companies

same main activity, similar in size and age
Company
PHARM-AD Jodoigne €659,306 €222,322 72.3% -
JAUCHUA3 Orp-Jauche €628,970 €199,447 82.1% -
SBInsight Grez-Doiceau €709,521 €220,568 85.2% -
SD SERVICES & MANAGEMENT Waterloo €621,909 €202,996 64.7% -
AUDIOLOGY CONSULTING Waterloo €813,524 €245,924 9.8% -
X-IMUS Bonheiden €702,159 €228,571 27.1% -
LUI58 Chapelle-lez-Herlaimont €687,797 €209,655 85.6% -

These companies have the same main activity as PHARM-AD: other business support services (NACE 82990). They are comparable in size and age: total assets between €622,000 and €814,000, founded between 2008 and 2011.

Official details

Source: KBO
Status
Active since 03-10-2009Normal situation
Activity
Other business support servicesNACE 82990
Establishment unit
2.181.395.3861370 Jodoigne, since 03-10-2009
Financial year end
30 June
Peppol
Reachable since 17-02-2026
Company details

Annual accounts to 30-06-2025

≈ €330,000estimated
€659,306▼ 10.0%
Filing
Filed on 30-01-2026, 1 day before the end of the filing period
Financials

Insights on PHARM-AD

PHARM-AD files the micro format. That format states no turnover. The gross margin rose from €67,949 in 2010 to €222,322 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARM-AD

What is the company number of PHARM-AD?
The company number of PHARM-AD is 0819.236.165. The VAT number is the same number with BE in front: BE 0819.236.165.
Where is PHARM-AD based?
The registered office is at Rue Sainte-Gertrude (Piét.) 5, 1370 Jodoigne.Company details
What does PHARM-AD do?
According to the KBO register, the main activity is other business support services (NACE 82990).
What is the legal form of PHARM-AD?
PHARM-AD is a private limited company (BV).
When was PHARM-AD founded?
PHARM-AD was founded on 03-10-2009.
Is PHARM-AD still active?
Yes, PHARM-AD is an active enterprise in the KBO register.
What is the turnover of PHARM-AD?
The turnover in financial year 2025 is ≈ €330,000. This figure is estimated from the gross margin of €222,322 and 31 comparable companies (NACE 82990). It probably lies between €260,000 and €460,000.Financials
Is PHARM-AD profitable?
In financial year 2025, PHARM-AD made a profit of €150,580.
Where can I find the annual accounts of PHARM-AD?
PHARM-AD filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARM-AD due?
PHARM-AD must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.